AGR3 and breast carcinoma: The type-II histological grade (65%;p = 0.048; I2 = 95.33%),5, 11, 13ER positivity (72%;p = 0.000; I2 = 98.53%),5, 11, 13PR positivity (69%;p = 0.000; I2 = 96.74%),5, 11, 13negativity of Ki-67 expression (52%;p = 0.015; I2 = 90.16%),5, 13recurrence or distant metastasis (55%;p = 0.001; I2 = 0%).13and luminal subtypes A (46%) and B (48%) (p = 0.000; I2 = 94.06%)13have been associated with positive AGR3 expression in women with breast cancer.